Cenicriviroc
Cenicriviroc
Cenicriviroc (pronounced: sen-ick-ri-vi-roc) is a type of pharmaceutical drug used in the treatment of various medical conditions.
Etymology
The term "Cenicriviroc" is derived from the combination of the words "Cenic" and "Riviroc". The exact etymology is not known, but it is believed to be a coined term by the pharmaceutical company that developed the drug.
Usage
Cenicriviroc is an investigational drug that is being studied for its potential use in the treatment of HIV and non-alcoholic steatohepatitis (NASH). It is a dual CCR2/CCR5 antagonist, which means it blocks the action of certain proteins that can cause inflammation and damage in the body.
Related Terms
- CCR2: A protein that Cenicriviroc blocks to reduce inflammation.
- CCR5: Another protein that Cenicriviroc blocks to reduce inflammation.
- HIV: A virus that Cenicriviroc is being studied to treat.
- Non-alcoholic steatohepatitis (NASH): A liver disease that Cenicriviroc is being studied to treat.
See Also
External links
- Medical encyclopedia article on Cenicriviroc
- Wikipedia's article - Cenicriviroc
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski